73 results
8-K
EX-99.1
AEMD
Aethlon Medical Inc
14 Nov 23
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
4:15pm
with the closed COVID trial, a $261,000 decrease in the purchase of raw materials for research and development testing for use in the Hemopurifier
8-K
EX-99.1
AEMD
Aethlon Medical Inc
10 Aug 23
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
4:20pm
a $344,000 increase in purchase of raw materials for production of the company’s Hemopurifier, $133,000 increase related to the Australian
8-K
EX-99.2
kfddh k5k4v
19 Sep 22
Departure of Directors or Certain Officers
5:00pm
424B5
pvsb9us5kywr9ei
11 Jun 21
Prospectus supplement for primary offering
5:27pm
424B5
85fhpybd
22 Mar 21
Prospectus supplement for primary offering
5:01pm